Article Versions Notes

Khan S, Jandrajupalli SB, Bushara NZA, Raja RDP, Mirza S, Sharma K, Verma R, Kumar A, Lohani M. Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine. Cells. 2024; 13(24):2126. https://doi.org/10.3390/cells13242126

Khan, Saif, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, Rama Devi Patel Raja, Shadab Mirza, Kuldeep Sharma, Rajan Verma, Ashish Kumar, and Mohtashim Lohani. 2024. "Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine" Cells 13, no. 24: 2126. https://doi.org/10.3390/cells13242126

Khan, S., Jandrajupalli, S. B., Bushara, N. Z. A., Raja, R. D. P., Mirza, S., Sharma, K., Verma, R., Kumar, A., & Lohani, M. (2024). Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine. Cells, 13(24), 2126. https://doi.org/10.3390/cells13242126